Cassava Sciences Shares Fall On Phase 2 Alzheimer’s Trial Results
Editor's note: The headline of this story has been updated to more accurately reflect the results of the Cassava Sciences Phase 2 trial for simufilam.
Google Layoffs 12K Employees, Netflix’s Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly’s Alzheimer’s Candidate: Top Stories Friday, Jan. 20
Here's a round-up of stories from around the globe and from various media outlets.
Benzinga
FDA Rejects Eli Lilly’s Donanemab For Alzheimer’s Disease, Needs More Data
The FDA issued a complete response letter for the accelerated approval submission of Eli Lilly And Co’s (NYSE:LLY) donanemab for early symptomatic…
Analyst Views Novo Nordisk’s Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly’s Tirzepatide
Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.
AbbVie, Eli Lilly Leave UK’s Voluntary Medicines Pricing Agreement Over Increasing Prices
The Association of the British Pharmaceutical Industry (ABPI) said pharmaceutical giants AbbVie Inc (NYSE:ABBV) and Eli Lilly And Co (NYSE:LLY) have withdrawn from Britain’s…
Top-Performing Hedge Fund In 2022 Has This Strategy To Thank: How Much Did It Make Last Year?
Macro trading is an investment strategy that takes into account both domestic and global macroeconomic trends.
SAVA, LLY, IBB: Why These Alzheimer’s Related Stocks Are Volatile On Friday
Stocks of companies with Alzheimer's candidates, including Cassava Sciences, Inc. (NASDAQ: SAVA) and Eli Lilly And Company (NYSE: LLY), spiked on Friday after the FDA granted accelerated approval to
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Jim Cramer Says Avoid This Stock: ‘Too Expensive’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money.